BackenVVeno Medical - Warrants (30/05/2023) Overview

enVVeno Medical - Warrants (30/05/2023) Receivables

Track enVVeno Medical - Warrants (30/05/2023)'s receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

enVVeno Medical - Warrants (30/05/2023) Receivables History

Loading

enVVeno Medical - Warrants (30/05/2023) vs. peers: Receivables Comparison

Loading

enVVeno Medical - Warrants (30/05/2023) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

enVVeno Medical - Warrants (30/05/2023) (NVNOW) FAQ

The latest receivables for NVNOW is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside enVVeno Medical - Warrants (30/05/2023)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NVNOW's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in enVVeno Medical - Warrants (30/05/2023)'s operating scale or balance-sheet position.

A receivables figure of $0 for NVNOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVNOW's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack enVVeno Medical - Warrants (30/05/2023)'s receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.